{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is HilleVax, Inc. technically bullish or bearish?
As of June 20, 2025, HilleVax, Inc. is in a mildly bullish trend, supported by mixed technical indicators including a bullish MACD and moving averages, but tempered by bearish signals from the KST and mixed Bollinger Bands.
What does HilleVax, Inc. do?
HilleVax, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry with a market cap of $92.76 million and a net profit of -$6 million as of March 2025. It has a P/E ratio of NA, a dividend yield of 0.00%, and a negative return on equity of -47.47%.
How big is HilleVax, Inc.?
As of Jun 18, HilleVax, Inc. has a market capitalization of 92.76 million and reported net sales of 0.00 million with a net profit of -106.50 million over the last four quarters. Shareholder's funds are 154.49 million, and total assets are 192.69 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
